GSK plc has announced the purchase of 310,000 of its own ordinary shares as part of its ongoing buyback program. This transaction, executed through BNP Paribas SA, is part of a broader strategy to ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has recently updated its clinical study ...

The pharmaceutical and biotechnology company GlaxoSmithKline has fired one of their employees who launched into a homophobic and racist rant whilst on an American Airlines flight. In viral video ...

The pharma giant appears to be skirting its own price cap through an arrangement with a generic manufacturer, Sen. Maggie Hassan charges Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge ...

Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

Amid a report that the COVID-19 antibody treatment from Regeneron loses its effectiveness against the omicron variant, GlaxoSmithKline and Vir Biotechnology said on Tuesday that their antibody drug is ...

Last January, when GlaxoSmithKline’s ViiV Healthcare won a long-awaited approval for its long-acting HIV treatment Cabenuva, it was hailed as a game-changer as it removed the burden of taking a daily ...

The positions in the table below reflect the GlaxoSmithKline USA's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. July 14, 2010— -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their ...